All Expert Theaters are non-CME, industry-presented educational sessions that take place in the room designated in the schedule. During each session, a meal will be served. Each session is limited to 40 participants and seating is first-come, first-served.

Monday, March 11

Threat of Rabies Virus Infections in the US and the Role of Postexposure Prophylaxis

Presented by: Grifols
Speaker: Dr. Charles Rupprecht, Expert Technical Advisor on Rabies, PAHO/WHO

12:30 pm – 1:15 pm | Crystal Ballroom GH

This educational program will cover the prevalence of rabies in the US, pathogenesis, diagnosis, and most up-to-date treatment guidelines and best practices.

Dr. Charles Rupprecht presently serves as a subject matter expert with academia, government, industry, and NGOs, as well as an Expert Technical Advisor on Rabies for the PAHO/WHO. For approximately 20 years, Dr. Rupprecht was the Chief of the Rabies Program at the CDC and is lead author of the CDC-ACIP guidelines for Postexposure Prophylaxis to Prevent Human Rabies.

Emergency Medicine: Hot Topics and Strategies for Navigating an Evolving Environment

Presented by: R1
Speakers: Colby Payne, VP Customer Success, R1(moderator); Jeffrey Bettinger, MD, FACEP, Managing Member, Bettinger, Stimler & Associates, LLC; Jacquie Bratcher, CPC, CEDC, Sr. Director, Coding, R1; Michael Driskill, CPC, Director, Coding Operations, R1

12:30 pm – 1:15 pm | Crystal Ballroom F

With reimbursement reduction, expanding regulations, and insurance denials, the financial environment gets tougher each year for providers. Hear coding and reimbursement experts discuss many of the challenges facing emergency medicine and key strategies for navigating this dynamic landscape.

Tuesday, March 12

MIPS, EQUAL, CEDR, EMDI: Making Cents of the Quality and Payment Alphabet Soup

Presented by: ACEP E-QUAL
Speakers: Arjun Venkatesh MD, MBA, MHS; Pawan Goyal, MD, MHA, CBA, PMP, FHIMSS, FAHIMA, CPHIMS

7:00 am - 7:45 am | Crystal Ballroom GH

During this session, the speakers will review upcoming changes to the CMS MIPS pay for performance program for 2024, as well as trends in ED quality data from EMDI. You will also learn how to identify opportunities and tools to improve ROI and reduce the burden of quality improvement activities with E-QUAL. Finally, you'll learn the current state - and future direction - of quality measures in EM and the CEDR registry to chart a plan in your emergency department.

Operationalizing DALVANCE (dalbavancin)

Presented by: AbbVie
Speaker: Dr. Justin Schmetterer, PharmD, Infectious Disease Specialist, Presbyterian Healthcare Services

12:00 pm - 12:45 pm | Crystal Ballroom F

This program provides crucial insights and dependencies within institutions to assist them in overcoming barriers related to the administration, coding, billing, and reimbursement processes associated with Dalvance.

This presentation is intended for the US Healthcare Decision Makers audience (i.e., ED Pharmacy directors).

Be the Difference: Similar Outcomes & Superior Patient Comfort

Presented by: Vapotherm
Speaker: Jaime Betancourt, MD, Pulmonary Intensivist and Associate Clinical Professor of Medicine

12:00 pm - 12:45 pm | Crystal Ballroom GH

The Vapotherm Physician presenter will review the mechanisms of action, scientific evidence and clinical applications of high velocity therapy, a mask-free noninvasive ventilation solution for spontaneously patients in respiratory distress in the ED, including hypercapnia, hypoxemia and dyspnea. The presentation will highlight the findings of a recent randomized, multicenter controlled trial, and SCCM Star Research Award presentation, that successfully challenges the accepted standard treatment for patients with an acute exacerbation of moderate-severe COPD. The lecture will explain how the treatment of acute hypercapnic respiratory failure due to COPD with high velocity therapy was shown to be a reasonable alternative to NIPPV in relieving dyspnea with similar physiological benefit including decreases in PCO2.